Inpare ApS: Financial statements 2018
CVR: 37138789
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Inpare ApS (CVR 37138789) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -27,013 and a net result of DKK -26,070 compared with DKK -133,096 the year before. Equity in the 2018 report amounted to DKK -32,562. The company had 2 employees in the financial year.
- Gross Profit
- DKK -27,013
- Profit/Loss
- DKK -26,070
- Equity
- DKK -32,562
- Total Assets
- DKK 43,944
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Inpare ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -133,096.
As of March 21, 2018, Ole Pedersen has joined the board of directors of Inpare ApS.
As of March 21, 2018, Peter David Gruhn has left the board of directors of Inpare ApS.
As of March 21, 2018, Peter David Gruhn has stepped down as adm. dir. of Inpare ApS.
About Inpare ApS
Inpare ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 27 November 2024. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Lionheart Pharmaceuticals ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -218,796 and a net result of DKK -272,847 compared with DKK -142,714 the year before. Equity in the 2023 report amounted to DKK -735,535.